Regeneron Pharmaceuticals (REGN)
Equity Ratio
75.99%
Quarterly · Period ending:
REGN Equity Ratio
Latest reported75.99%period ending
Latest reported75.99%period ending
REGN Quarterly Equity Ratio (48.03% → 75.99%)
Latest values, visible window
High-resolution chart · PNG
REGN equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 93.1605% | |
| 92.9052% | |
| 87.4473% | |
| 88.2826% | |
| 87.0639% | |
| 79.9756% | |
| 79.927% | |
| 82.2173% | |
| 82.5465% | |
| 82.6524% | |
| 83.6201% | |
| 84.298% | |
| 83.4646% | |
| 83.891% | |
| 82.4822% | |
| 83.9101% | |
| 82.2941% | |
| 78.2339% | |
| 77.689% | |
| 79.7856% | |
| 80.9763% | |
| 72.0418% | |
| 72.3881% | |
| 71.4286% | |
| 71.223% | |
| 74.0999% | |
| 71.2314% | |
| 74.7433% | |
| 72.4693% | |
| 81.7925% | |
| 83.6735% | |
| 87.4504% | |
| 83.0097% | |
| 85.872% | |
| 89.0705% | |
| 89.5594% | |
| 91.3523% | |
| 91.8004% | |
| 93.1579% | |
| 95.0877% | |
| 94.8785% | |
| 48.0315% |